Compare Cassava Sciences Inc (FLNA) vs Hycroft Mining Holding Corporation Class A Common Stock (HYMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Hycroft Mining Holding Corporation Class A Common Stock — how do they compare? Cassava Sciences Inc trades at $0.71 (market cap $35.34M), while Hycroft Mining Holding Corporation Class A Common Stock trades at $16.9 (market cap $1.52B). The key difference: Hycroft Mining Holding Corporation Class A Common Stock is far larger — about 43× Cassava Sciences Inc's market cap, and Hycroft Mining Holding Corporation Class A Common Stock is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 38 Days and Hycroft Mining Holding Corporation Class A Common Stock for 0 Days on average.
| FLNA | HYMC | |
|---|---|---|
Market Cap | $35.34M | $1.52B |
Volume | 251,946 | 3,040,922 |
Sector | Health | Basic Materials |
52-Week High | $4.64 | $55.74 |
52-Week Low | $0.68 | $6.75 |
Typical Hold Time | 38 Days | 0 Days |
Enterprise Value | -$47.34M | $1.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.7434, down 3.39% today, with a bearish technical signal despite recent positive FDA news lifting a clinical hold on its epilepsy drug. The company shows improving quarterly EPS beats but remains unprofitable with negative cash flows. Analyst consensus is strongly bullish with 8 buy ratings versus 4 holds.
The outlook hinges on clinical progress—FDA clearance enables Phase 2a trials in 2027, a key catalyst. Risks include sustained cash burn and fiduciary concerns highlighted in recent news. Investors should weigh the high analyst optimism against fundamental weaknesses and regulatory execution risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Hycroft Mining Holding Corporation Class A Common Stock
Hycroft Mining Holding Corporation is a US mining company that owns and operates the Hycroft Mine, a gold and silver deposit in northern Nevada, producing and selling gold and silver from open-pit mining operations.
Read more on HYMC →
